Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omega Therapeutics Inc (NQ: OMGA )

7.770 +0.010 (+0.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,803
Open 7.640
Bid (Size) 6.660 (1)
Ask (Size) 7.800 (6)
Prev. Close 7.760
Today's Range 7.524 - 7.800
52wk Range 1.975 - 14.31
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO™ I Study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
From Omega Therapeutics
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga

Performance

YTD
+34.90%
+34.90%
1 Month
+46.60%
+46.60%
3 Month
+56.34%
+56.34%
6 Month
+52.35%
+52.35%
1 Year
-27.99%
-27.99%

More News

Read More
Nasdaq Up 50 Points; Gold Rises Over 1%
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Omega Therapeutics Could Offer 'Intriguing' Liver Cancer Drug, Analyst Says
Via Benzinga
Omega Therapeutics Touts Encouraging Preclinical Data In Liver Cancer Animal Models
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Omega Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2022
Via Benzinga
Omega Therapeutics Gets FDA Nod For Initial-Stage Liver Cancer Study
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
Via Benzinga
Omega Therapeutics Submits IND For Liver Cancer Candidate
Via Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
Coinbase, Moderna And 56 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
91 Biggest Movers From Friday
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
Omega Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
70 Biggest Movers From Friday
Via Benzinga
90 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.